Compass Ion Advisors, LLC Sharps Technology Inc. Transaction History
Compass Ion Advisors, LLC
- $759 Million
- Q3 2024
A detailed history of Compass Ion Advisors, LLC transactions in Sharps Technology Inc. stock. As of the latest transaction made, Compass Ion Advisors, LLC holds 57,143 shares of STSS stock, worth $22,857. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,143
Previous 57,143
-0.0%
Holding current value
$22,857
Previous $13,000
38.46%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding STSS
# of Institutions
11Shares Held
697KCall Options Held
0Put Options Held
0-
Garden State Investment Advisory Services LLC Red Bank, NJ173KShares$69,1630.01% of portfolio
-
Essential Planning, Llc. Portsmouth, NH163KShares$65,1300.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny137KShares$54,7460.0% of portfolio
-
Alpha Core Capital LLC La Jolla, CA88.6KShares$35,4290.0% of portfolio
-
Hrt Financial LP New York, NY36.2KShares$14,4640.0% of portfolio
About Sharps Technology Inc.
- Ticker STSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 9,207,420
- Market Cap $3.68M
- Description
- Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in...